Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Link, J; Ramanujam, R; Auer, M; Ryner, M; Hassler, S; Bachelet, D; Mbogning, C; Warnke, C; Buck, D; Jensen, PEH; Sievers, C; Ingenhoven, K; Fissolo, N; Lindberg, R; Grummel, V; Donnellan, N; Comabella, M; Montalban, X; Kieseier, B; Sorensen, PS; Hart

Fogdell-Hahn, A (reprint author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

PLOS ONE, 2017; 12 (2):

Abstract

Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索